Toll Free: 1-888-928-9744

Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2014

Published: Nov, 2014 | Pages: 39 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Tetraphase Pharmaceuticals Inc. - Product Pipeline Review - 2014', provides an overview of the Tetraphase Pharmaceuticals Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Tetraphase Pharmaceuticals Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Tetraphase Pharmaceuticals Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Tetraphase Pharmaceuticals Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Tetraphase Pharmaceuticals Inc.'s pipeline products

Reasons to buy

- Evaluate Tetraphase Pharmaceuticals Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Tetraphase Pharmaceuticals Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Tetraphase Pharmaceuticals Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Tetraphase Pharmaceuticals Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Tetraphase Pharmaceuticals Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Tetraphase Pharmaceuticals Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Tetraphase Pharmaceuticals Inc. Snapshot 5
Tetraphase Pharmaceuticals Inc. Overview 5
Key Information 5
Key Facts 5
Tetraphase Pharmaceuticals Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Tetraphase Pharmaceuticals Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Tetraphase Pharmaceuticals Inc. - Pipeline Products Glance 11
Tetraphase Pharmaceuticals Inc. - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Tetraphase Pharmaceuticals Inc. - Clinical Stage Pipeline Products 12
Phase I Products/Combination Treatment Modalities 12
Tetraphase Pharmaceuticals Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Tetraphase Pharmaceuticals Inc. - Unknown Stage Pipeline Products 15
Unknown Products/Combination Treatment Modalities 15
Tetraphase Pharmaceuticals Inc. - Drug Profiles 16
eravacycline 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Small Molecule for Bacterial Infections 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
TP-076 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
TP-138 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
TP-271 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
TP-433 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
TP-559 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
TP-600 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
TP-834 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Tetraphase Pharmaceuticals Inc. - Pipeline Analysis 28
Tetraphase Pharmaceuticals Inc. - Pipeline Products by Target 28
Tetraphase Pharmaceuticals Inc. - Pipeline Products by Route of Administration 29
Tetraphase Pharmaceuticals Inc. - Pipeline Products by Molecule Type 30
Tetraphase Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action 31
Tetraphase Pharmaceuticals Inc. - Recent Pipeline Updates 32
Tetraphase Pharmaceuticals Inc. - Dormant Projects 36
Tetraphase Pharmaceuticals Inc. - Locations And Subsidiaries 37
Head Office 37
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 38
Expert Panel Validation 38
Contact Us 39
Disclaimer 39
List of Tables
Tetraphase Pharmaceuticals Inc., Key Information 5
Tetraphase Pharmaceuticals Inc., Key Facts 5
Tetraphase Pharmaceuticals Inc. - Pipeline by Indication, 2014 8
Tetraphase Pharmaceuticals Inc. - Pipeline by Stage of Development, 2014 9
Tetraphase Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2014 10
Tetraphase Pharmaceuticals Inc. - Phase III, 2014 11
Tetraphase Pharmaceuticals Inc. - Phase I, 2014 12
Tetraphase Pharmaceuticals Inc. - Preclinical, 2014 13
Tetraphase Pharmaceuticals Inc. - Discovery, 2014 14
Tetraphase Pharmaceuticals Inc. - Unknown, 2014 15
Tetraphase Pharmaceuticals Inc. - Pipeline by Target, 2014 28
Tetraphase Pharmaceuticals Inc. - Pipeline by Route of Administration, 2014 29
Tetraphase Pharmaceuticals Inc. - Pipeline by Molecule Type, 2014 30
Tetraphase Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2014 31
Tetraphase Pharmaceuticals Inc. - Recent Pipeline Updates, 2014 32
Tetraphase Pharmaceuticals Inc. - Dormant Developmental Projects,2014 36 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify